Oral microbiome therapy efficacious for recurrent C. difficile infection
- PMID: 35105956
- DOI: 10.1038/s41575-022-00585-y
Oral microbiome therapy efficacious for recurrent C. difficile infection
Comment on
-
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516. N Engl J Med. 2022. PMID: 35045228 Clinical Trial.
References
Original article
-
- Feuerstadt, P. et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N. Engl. J. Med. 386, 220–229 (2022) - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
